EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients

Journal of the American Society of Nephrology

Volumn 9, Issue 5, 1998, Pages 869-876

  Hoen, Bruno ^a,b   Paul Dauphin, Agnès ^a   Hestin, Dominique ^a   Kessler, Michèle ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; CATHETER INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; FEMALE; HEMODIALYSIS; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; VASCULAR ACCESS;

EID: 0031959987     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kessler M, Hoen B, Mayeux D, Hestin D, Fontenaille C: Bacteraemia in patients on chronic haemodialysis. Nephron 64: 95-100, 1993
2. Goldblum SE, Reed WP, Which JA, Goldmann RS: Staphylococcus carriage and infections in haemodialysis patients. Dial Transplant 7: 1140-1148, 1978
3. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J, Zuravleff JJ: Staphylococcus aureus nasal carriage and infections in patients on hemodialysis. N Engl J Med 315: 91-96, 1986
4. Hoen B, Kessler M, Hestin D, Mayeux D: Risk factors for bacterial infections in chronic haemodialysis adult patients: A multicentre prospective survey. Nephrol Dial Transplant 10: 377-381, 1995
5. Cheesbrough YS, Finch RG, Burden RP: A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis 154: 579-589, 1986
6. Almirall J, Gonzales J, Rello J, Campistol JM, Montoliu J, Dela Bellasca JP, Revert L, Gatell JM: Infection of hemodialysis catheters: Incidence and mechanisms. Am J Nephrol 9: 454-459, 1989
7. Boelaert JR, Daneels RF, Schurgers ML, Matthys EG, Gordts BZ, Van Landuyt HW: Iron overload in haemodialysis patients increases the risk of bacteraemia: A prospective study. Nephrol Dial Transplant 5: 130-134, 1990
8. Tielemans CL, Lenclud CM, Wens R, Collart FE, Dratwa M: Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections: Beneficial effects of desferrioxamine. Nephrol Dial Transplant 4: 883-887, 1989
9. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, McKenzie JK, Muithead N, Parfrey PS, Posen GA, Slaughter D, Ulan RA, Werb R: Canadian haemodialysis morbidity study. Am J Kidney Dis 19: 214-234, 1992
10. Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high flux dialysis. J Am Soc Nephrol 3: 1227-1237, 1993
11. Bonomini V, Coli L, Scolari MP, Stefoni S: Structure of dialysis membranes and long-term clinical outcome. Am J Nephrol 15: 455-462, 1995
12. Daugirdas JT: Bedside formulas for KT/V: A kinder, gentler approach to urea kinetic modeling. ASAIO Trans 35: 336-338, 1989
13. Canaud B, Béraud JJ, Joyeux H, Mion C: Internal jugular vein cannulation with two silicone rubber catheters. A new and safe temporary vascular access for haemodialysis: 30 months experience. Artif Organs 10: 397-403, 1986
14. Shaffer D: Catheter-related sepsis complicating long-term, tunneled central venous dialysis catheters: Management by guide-wire exchange. Am J Kidney Dis 25: 593-596, 1995
15. Glowacki LS, Hodsman AB, Hammerberg O, Meraw J, McNeill V, Card ML, Potters H, McGhie K, Stitt LW: Surveillance and prophylactic intervention of Staphylococcus aureus nasal colonization in a hemodialysis unit. Am J Nephrol 14: 9-13, 1994
16. Boelaert JR, Van Landuyt HW, Godard CA, Daneels RF, Schurgers ML, Matthys EG, De Baere YA, Gheyle DW, Gordts BZ, Herwaldt LA: Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 8: 235-239, 1993
17. Montagnac R, Eloy C, Schillinger F, Croix JC, Milcent T: Etude itérative de la prévalence du portage nasal de Staphylococcus aureus chez l'hémodialysé. Presse Med 24: 1075-1077, 1995
18. Roubicek C, Brunet P, Mallet MN, Dussol B, Gonzales A, Andrieu D, Merzouk T, Jaber K, Berland Y: Portage nasal de Staphylococcus aureus: Prévalence dans un centre d'hémodialyse et influence sur les bactériémies. Néphrologie 16: 229-232, 1995
19. Layton MC, Patterson JE: Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacilline-resistant Staphylococcus aureus at a university hospital. Antimicrob Agents Chemother 38: 1664-1667, 1994
20. Boelaert JR, Cantinieaux BF, Hariga CF, Fondu PG: Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. Nephrol Dial Transplant 5: 504-507, 1990
21. Veys N, Vanholder R, Ringoire S: Correction of deficient phagocytosis during erythropoietin treatment in maintenance haemodialysis patients. Am J Kidney Dis 19: 358-363, 1992
22. Keane WF, Collins AJ: Influence of co-morbidity on mortality and morbidity in patients treated with haemodialysis. Am J Kidney Dis 24: 1010-1018, 1994
23. Vanholder R, Ringoir S, Dhondt A, Hakim R: Phagocytosis in uremic and haemodialysis patients: A prospective and cross sectional study. Kidney Int 39: 320-327, 1991
24. Himmelfarb J, Zaoui P, Hakim R, Holbroock D: Modulation of granulocyte LAM-I and MAC-I during dialysis: A prospective randomized controlled trial. Kidney Int 41: 388-397, 1992
25. Churchill DN: Clinical impact of biocompatible dialysis membranes on patient morbidity and mortality: An appraisal of the evidence. Nephrol Dial Transplant 10[Suppl 10]: 52-56, 1995